Answers are grounded in this paper and cite their sources.
We aimed to investigate the glaucoma-detecting ability of MEOCHECK, a novel and simple visual field measurement device based on retinal projection technology. This retrospective and observational study evaluated 94 glaucomatous eyes of 49 subjects and 31 non-glaucomatous eyes of 23 healthy subjects. We compared MEOCHECK's main output, Score 100, to visual acuity, intraocular pressure, optical coherence tomography-measured parameters (circumpapillary retinal nerve fiber layer thickness [cpRNFLT] and ganglion cell complex thickness [GCCT]), and automated perimetry-measured mean deviation (MD) in glaucomatous eyes. Score 100 showed significant correlations with age, visual acuity, cpRNFLT, GCCT, and MD (r = --0.38, p < 0.001; r = -0.42, p < 0.001; r = 0.65, p < 0.001; r = 0.59, p < 0.001; and r = 0.62, p < 0.001, respectively). Score 100 was statistically significantly lower in early- vs. moderate-stage glaucoma (p = 0.03) and in moderate- vs. severe-stage glaucoma (p = 0.002). A logistic regression analysis indicated that Score 100 could predict the presence of glaucoma, with an area under the receiver operating characteristic curve of 0.89. MEOCHECK, a novel device that uses retinal projection technology, effectively detected glaucomatous visual fields, demonstrating its potential as a reliable tool for glaucoma detection.
No takes yet. Share an insight, caveat, or question.
Tsuda et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: